ClinicalTrials.Veeva

Menu

Study to Evaluate the Performance of the Therma COVID-19 Rapid Antigen Test for Detection of SARS-CoV-2

C

Cannabis Research Associates

Status

Unknown

Conditions

Covid19

Treatments

Device: Theram COVID-19 Rapid Antigen Test

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

The Therma COVID-19 Rapid Antigen Test is an in vitro rapid, lateral flow immunoassay intended for the qualitative detection of SARS-CoV-2 nucleocapsid protein antigens in human saliva specimens. This test is intended for near-patient use at the point-of-care or lay person, self-use in a non-laboratory or home setting using saliva samples from individuals with or without symptoms of COVID-19.

The Therma COVID-19 Rapid Antigen Test will be compared to a Health Canada approved RT-PCR COVID-19 test. Nasopharyngeal (for RT-PCR) samples will be collected at a COVID-19 Testing centre and saliva (for the rapid antigen test) samples will be collected and compared.

The prospective, observational, feasibility study will test 300 participants to establish the performance characteristics of the test on saliva specimens.

Enrollment

300 estimated patients

Sex

All

Ages

12+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Participant is willing to sign verbal informed consent form
  2. Age 12 or older and parents or legal guardians must consent for children as required by law.
  3. Participant is attending COVID-19 testing centre for a nasopharyngeal swab sample
  4. Participant is willing to provide a self-collected saliva sample

Exclusion criteria

  1. Participant has previously tested positive for COVID-19 within the past 90 days

Trial design

300 participants in 1 patient group

Rapid Antigen Saliva Test
Description:
Participants who have had a COVID-19 PCR test will self-administer the saliva test. The research team will conduct the processing of the test for the results of positive, negative or inconclusive
Treatment:
Device: Theram COVID-19 Rapid Antigen Test

Trial contacts and locations

0

Loading...

Central trial contact

Lisa Patterson, BA; Ira Price, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems